![]() 75 YEARS TRADITION AND MODERN APPROACH – modern production, European quality standards, corporate social responsibility. In 1993 the pharmaceutical community united in its economic organization “Bulgarian Pharmacy Cooperative Company” starts the construction of the first production laboratory for production of medicinal products in the country. The products produced in the laboratory of the company – ampoules, tablets, extracts, chemical products, hygiene and cosmetics – their variety and number show the advancements and achievements in the pharmaceutical production in Bulgaria. Scientifically tested onsite, the products become popular with their high quality. In 1942 the production laboratory of the Bulgarian Pharmacy Cooperative Company moves in a building especially constructed for its needs on “Iliensko shousee” and grows into “Galenus” – a pharmaceutical plant in which better conditions are a prerequisite for faster development. This leads to increase of production capacity and widening of the product portfolio. “Galenus” is the first modern industrial plant for production of medicinal products on the Balkan Peninsula, competing with popular German and Swiss companies. In 1953 all machines for the production of solid forms are moved into the “Galenus” plant. The average production capacity of one machine reaches 5,576 tablets per hour. The main products are Aspirin, Chinin and Doverin produced with imported and high quality raw materials. In the same year, after the nationalization, the “Galenus” plant is renamed into Chemical-pharmaceutical plant – the ancestor of Sopharma. For the period 1953-2000 Sopharma is the leading pharmaceutical producer in Bulgaria. In September 2000 after a successful privatization Sopharma becomes a private pharmaceutical company. The first years after privatization are a period of constant modernization and improvement. For the two years after the privatization period Sopharma unites six enterprises in a modern and dynamic corporate structure including: Sopharma AD, Unipharm ASD, Vramed AD, Pharmachim Holding AD, NIFHI AD and Rostbalkanpharm. In 2003 the President of the Republic of Bulgaria George Parvanov officially opened the new pharmaceutical plant “Sopharma – Vrabevo”. In this modern plant for production of medicinal products Sopharma invested 20 million BGN. Each step of the construction of the plant followed internationally accepted GMP (Good Manufacturing Practices) standards. In 2004 Sopharma licensed its production facilities according to the European GMP which secured its strategic position after the EU accession in 2007. In the same year Sopharma increased its production capacity by adding another member to its group of companies - Bulgarian Rose - Sevtopolis AD. In 2005 Sopharma opened the most modern logistics center in Bulgaria (logistics terminal) for distribution of pharmaceutical products. The logistics center fully complies with the European Good Distribution Practice (GDP). In 2006 Sopharma initiated the planning and construction process of a new highly technological tablet factory for the production of solid forms with doubled capacity and investment potential of over 40 million EUR. All activities related to planning, construction and validation fully comply with the European standards for pharmaceutical production and are approved by the Bulgarian Health Agency. For this project Sopharma received the First Class Investor Award. In 2007 Sopharma made the next step in modernization and increased production capacity in the tablet production of Bulgarian Rose - Sevtopolis AD, Kazanlak. The official opening of the new plant for pharmaceutical substances took place in 2008. Being the only producer of ampoules in Bulgaria in 2007 Sopharma undertook a reconstruction of its ampoule facility in order to increase its production capacity. With its 75 year history Sopharma is a symbol of success today. |
Corporate information
